Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Combining RNA-Seq FASTQ files for coverage issues

    Hi:

    As a pilot experiment I ordered RNA-Seq on following plan:

    3 different conditions
    1 sample per condition.
    No replicates.

    I had 50M reads coverage for each sample 100bp PE.

    Second time, I went with 4 replicates. However I have a problem now with coverage:

    50bp PE reads

    25M coverage for every replicate sample. As there was some space on flow-cell, seq lab ran same libraries on extra lane.

    That extra lane also gave 25M coverage.

    I was asked to combine FASTq files from two lanes into one FASTQ file suggesting it will make up to 50M reads. It does not make sense to me.

    Is that a common practice? what experts suggest here?

    Thanks
    Adrian

  • #2
    That's fine, presuming that the libraries run on the two lanes were the same (i.e., a separate library wasn't made for the additional lane). Combining technical replicates is normally OK.

    Comment


    • #3
      The problem with a large difference in read count between samples is that the high read count sample will find low expression genes and the low read count sample will not find those genes which can result in false positives.

      Comment

      Latest Articles

      Collapse

      • seqadmin
        Understanding Genetic Influence on Infectious Disease
        by seqadmin




        During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

        Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
        09-09-2024, 10:59 AM
      • seqadmin
        Addressing Off-Target Effects in CRISPR Technologies
        by seqadmin






        The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
        08-27-2024, 04:44 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by seqadmin, Today, 02:44 PM
      0 responses
      7 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 09-06-2024, 08:02 AM
      0 responses
      143 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 09-03-2024, 08:30 AM
      0 responses
      150 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 08-27-2024, 04:40 AM
      0 responses
      158 views
      0 likes
      Last Post seqadmin  
      Working...
      X